Overview

Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer

Status:
Withdrawn
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Investigation of the effects of daily sildenafil on patients with pancreatic or cholangiocarcinoma cancer undergoing treatment.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Treatments:
Sildenafil Citrate